Skip to main content
Have a personal or library account? Click to login
The Effects of Cisplatin and Its PT(II) Analogue on Oxidative Stress of Isolated Rat Heart/ Efekti Cisplatine I PT(II) Analoga Cisplatine Na Oksidacioni Stres Izolovanog Srca Pacova Cover

The Effects of Cisplatin and Its PT(II) Analogue on Oxidative Stress of Isolated Rat Heart/ Efekti Cisplatine I PT(II) Analoga Cisplatine Na Oksidacioni Stres Izolovanog Srca Pacova

EABR. Experimental and Applied Biomedical Research
Volume 17 (2016): Issue 1 (March 2016)
By: ,  ,  ,  ,  ,   and    
Open Access
|Apr 2016
References

References

  1. 1. Jakupec MA, Galanski M, Keppler BK. Tumour-inhibiting platinum complexes-state of the art and future perspectives. Rev Physiol Biochem Pharmacol. 2003; 146: 1-53.
    Open DOISearch in Google Scholar
  2. 2. Wong E, Giandomenico CM. Current Status of Platinum- Based Antitumor Drugs. Chem. Rev. 1999; 99(9): 2451-66.
    Search in Google Scholar
  3. 3. Desoize B, Madoulet C. Particular aspects of platinum compound used at present in cancer treatment. Crit Rev Oncol Hematol. 2002; 42(3): 317-25.
    Open DOISearch in Google Scholar
  4. 4. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007; 33(1): 9-23.
    Open DOISearch in Google Scholar
  5. 5. Bugarcic ZD, Bogojeski J, Petrovic B, Hochreuther S, Eldik R. Mechanisitic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur- donor biomolecules. Dalton Trans. 2012; 41(40): 12329-45.
    Open DOISearch in Google Scholar
  6. 6. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014; 740: 364-78.
    Open DOISearch in Google Scholar
  7. 7. Schimmel KJM, Richel DJ, Van Den Brink RBA, Guchelaar HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004; 30(2): 181-91.
    Open DOISearch in Google Scholar
  8. 8. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin Nephrotoxicity: A Review. The Am J Med Sci. 2007; 334(2): 115-24.
    Open DOISearch in Google Scholar
  9. 9. Miller PR, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin Nephrotoxicty. Toxins. 2010; 2(11): 2490-518.
    Open DOISearch in Google Scholar
  10. 10. Mc Whinney SR, Goldberg RM, Mc Leod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther. 2009; 8(1): 10-6.
    Open DOISearch in Google Scholar
  11. 11. Ding D, Allman BL, Salvi R. Review: Ototoxic Characteristics of Platinum Antitumor Drugs. Anat Rec (Hoboken). 2012; 295(11): 1851-67.
    Open DOISearch in Google Scholar
  12. 12. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol. 2009; 61(3): 223-42.
    Open DOISearch in Google Scholar
  13. 13. Döring HJ, Dehnert H. The isolated perfused warmblooded heart according to Langendorff. In: Döring C (Ed.): Methods in Experimental Physiology and Pharmacology. Biological Measurement Techniques. Berlin, Germany: Biomesstechnik-Verlag, 1988: pp. 1-129
    Search in Google Scholar
  14. 14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2): 351-8.
    Open DOISearch in Google Scholar
  15. 15. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982; 126(1): 131-8.
    Open DOISearch in Google Scholar
  16. 16. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenvvald Ra Hadnbook of methods for oxygen radical research. CRC Press Une, Boca Raton. 1985: 123-32.
    Search in Google Scholar
  17. 17. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J immunol Methods. 1980: 38(1-2); 161-70.
    Open DOISearch in Google Scholar
  18. 18. Jordan P, Carmo-Fonesca M. Molecular mechanisms invoved in cisplatin cytotoxicity. Cell Mol. Life Sci. 2000; 57(8-9): 1229-35.
    Open DOISearch in Google Scholar
  19. 19. Arola OJ, Saraste A, Pulkki K et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000; 60(7): 1789-92.
    Search in Google Scholar
  20. 20. Icli F, Karaouguz H, Dincol D et al. Sever vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 1993; 72(2): 587-93.
    Open DOISearch in Google Scholar
  21. 21. Dieckmann KP, Struss WJ, Budde U. Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour. Anticancer res. 2011; 31(12): 4501-6.
    Search in Google Scholar
  22. 22. Galanski M, Keppler BK. Synthesis and characterization of new ethylendiamine platinum(IV) complexes containg lipophilic carboxylate ligands. Metal Based Drugs. 1995; 2: 57-63.
    Open DOISearch in Google Scholar
  23. 23. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents. Drug Saf. 2000; 22(4): 263-302.
    Open DOISearch in Google Scholar
  24. 24. Ferroni P, Della-Monte D, Palmirotta R et al. Platinumbased compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention. Rejuventation Res. 2011; 14(3): 293-308.
    Open DOISearch in Google Scholar
  25. 25. Al-Majed AA, Sayed-Ahmed AA, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA. Propionyl-L-carnitine prevents the progression of cisplatin-induces cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res. 2010; 53(3): 278-86.
    Open DOISearch in Google Scholar
  26. 26. Ma H, Jones KR, Guo R, Xu P, Shan Y, Ran J. Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure: role of endoplasmic reticulum stress. Clin. Exp. Pharmacol. Physiol. 2010; 37(4): 460-5.
    Search in Google Scholar
  27. 27. Yousef MI, Saad AA, El-Shennawy LK. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol. 2009; 47(6): 1176-83.
    Open DOISearch in Google Scholar
  28. 28. Damian G. Deavall, Elizabeth A.Martin, Judith M. Horner, and Ruth Roberts. Drug-Induced Oxidative Stress and Toxicity. J Toxicol. 2012; 1-13.
    Open DOISearch in Google Scholar
  29. 29. Yuce A, Atessahin A, Ceribasi AO, Aksakal M. Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clin Pharmacol Toxicol. 2007; 101(5): 345-9.
    Open DOISearch in Google Scholar
  30. 30. El-Sawalhi MM, Ahmed LA. Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, In cisplatin-induced cardiotoxicityin rats. Chem Biol Interact.2014; 207: 58-66.
    Open DOISearch in Google Scholar
  31. 31. Hussein A, Ahmed AAE, Shouman SA, Sharawy S. Ameliorating effect of DL-α-lipoic acid against cisplatin- induced nephrotoxicity and cardiotoxicity in experimental animals. Drug Discov Ther. 2012; 6(3): 147-56.
    Open DOISearch in Google Scholar
  32. 32. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 2003; 142(3): 178-86.
    Open DOISearch in Google Scholar
  33. 33. Sawicka E, Długosz A, Jedrzejczyk J. Antioxidative Enzyme Activities after Exposure to KP972 and Cisplatin. Adv Clin Exp Med 2011; 591-7.
    Search in Google Scholar
  34. 34. Kadikoylu G, Bolaman Z, Demir S, Balkaya M, Akalin N, Enli Y. The effects of desferrioxamine on cisplatin induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Toxicol 2004; 23(1): 29-/34.
    Open DOISearch in Google Scholar
  35. 35. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical Mechanisms of Cisplatin Cytotoxicity. Anticanc Anticancer Agents Med Chem. 2007; 7(1): 3-18.
    Open DOISearch in Google Scholar
  36. 36. Martins NM, Santos NA, Curti C, Bianchi ML, Santos AC. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Toxicol. 2008; 28(3): 337-44.
    Search in Google Scholar
  37. 37. Ko JW, Lee IC, Park SH. Protective effects of pine bark extract against cisplatininduced hepatotoxicity andoxidative stress in rats. Lab Anim Res. 2014; 30(4): 174-80.
    Open DOISearch in Google Scholar
  38. 38. Antunes LMG, Darin JDC, Bianchi MDL. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dosedependent study. Pharmacol Res. 2000; 41(4): 406-11.
    Search in Google Scholar
  39. 39. Ciftci O, Ozdemir I, Vardi N, Gurbuz N. Novel platinum- N-heterocyclic carbine complex is more cardiotoxic than cis-platin in rats. Hum Exp Toxicol. 2010; 30(9): 1342-9
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2015-0050 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 15 - 20
Submitted on: Sep 9, 2015
Accepted on: Sep 11, 2015
Published on: Apr 14, 2016
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
isolated rat heart,
oxidative stress,
noveletilendiamin complex of platinum,
cisplatin
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Isidora Stojic, Vladimir Zivkovic, Ivan Srejovic, Nevena Jeremic, Vladimir Jakovljevic, Dragan Djuric, Slobodan Novokmet, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 17 (2016): Issue 1 (March 2016)
Previous article
Next article